The Economic Impact of a Switch From Prescription-Only to Non-prescription Drugs in Italy
The paper analyses the potential economic impact of switching drugs from prescription-only to over the counter status, using Italy as a case-study. The study assumes a societal perspective, investigating the effects of switches (and consequent delisting) on drugs spending, avoided visits by GPs (Gen...
Main Authors: | Monica Hildegard Otto, Carla Pillarella, Claudio Jommi |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2018-10-01
|
Series: | Frontiers in Pharmacology |
Subjects: | |
Online Access: | https://www.frontiersin.org/article/10.3389/fphar.2018.01069/full |
Similar Items
-
Corrigendum: The Economic Impact of a Switch From Prescription-Only to Non-prescription Drugs in Italy
by: Monica Hildegard Otto, et al.
Published: (2019-03-01) -
Potential Rx-to-OTC Switch Drug Candidates
by: Victor Phan, et al.
Published: (2016-02-01) -
Prescription and Non-Prescription Drug Classification Systems Across Countries: Lessons Learned for Thailand
by: Leelavanich D, et al.
Published: (2020-11-01) -
Suspected inappropriate use of prescription and non-prescription drugs among requesting customers: A Saudi community pharmacists’ perspective
by: Ayesha Yasmeen, et al.
Published: (2023-07-01) -
Early access programs for medicines: comparative analysis among France, Italy, Spain, and UK and focus on the Italian case
by: Alice Tarantola, et al.
Published: (2023-05-01)